Challenges to the Paclitaxel/Carboplatin Algorithm in Ovarian Cancer Treatment

被引：0
|
作者：
Zorn, Kristin K. [1 ]
机构：
[1] UPMC, Magee Womens Hosp, Gynecol Canc Program, Pittsburgh, PA USA
来源：
ONCOLOGY-NEW YORK | 2010年 / 24卷 / 08期
关键词：
GYNECOLOGIC-ONCOLOGY-GROUP; CISPLATIN; CYCLOPHOSPHAMIDE; PACLITAXEL; CARCINOMA; TRIAL;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：738 / 740
页数：2
相关论文
共 50 条
  • [41] Evaluation of combined bevacizumab and intraperitoneal carboplatin or paclitaxel therapy in a mouse model of ovarian cancer
    Shah, Dhaval K.
    Veith, Jean
    Bernacki, Ralph J.
    Balthasar, Joseph P.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2011, 68 (04) : 951 - 958
  • [42] Kinetic modeling and efficacy of intraperitoneal paclitaxel combined with intravenous cyclophosphamide and carboplatin as first-line treatment in ovarian cancer
    Hofstra, LS
    Bos, AME
    de Vries, EGE
    van der Zee, AGJ
    Willemsen, ATM
    Rosing, H
    Beijnen, JH
    Mulder, NH
    Aalders, JG
    Willemse, PHB
    GYNECOLOGIC ONCOLOGY, 2002, 85 (03) : 517 - 523
  • [43] Looking beyond carboplatin and paclitaxel for the treatment of advanced/recurrent endometrial cancer
    Rubinstein, Maria
    Shen, Sherry
    Monk, Bradley J.
    Tan, David S. P.
    Nogueira-Rodrigues, Angelica
    Aoki, Daisuke
    Sehouli, Jalid
    Makker, Vicky
    GYNECOLOGIC ONCOLOGY, 2022, 167 (03) : 540 - 546
  • [44] Comparison of quality of life of patients on treatment with cisplatin and gemcitabine, carboplatin and gemcitabine, carboplatin and paclitaxel, carboplatin and pemetrexed for non-small cell lung cancer
    Saranya, K.
    Sreejith, K.
    Ajaykumar
    JOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 1853 - 1859
  • [45] Treatment of advanced ovarian carcinoma with carboplatin and paclitaxel in a patient with renal failure
    Jeyabalan, N
    Hirte, HW
    Moens, F
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2000, 10 (06) : 463 - 468
  • [46] Results of reinduction therapy with paclitaxel and carboplatin in recurrent epithelial ovarian cancer
    Gronlund, B
    Hogdall, C
    Hansen, HH
    Engelholm, SA
    GYNECOLOGIC ONCOLOGY, 2001, 83 (01) : 128 - 134
  • [47] Paclitaxel and carboplatin combination chemotherapy in a hemodialysis patient with advanced ovarian cancer
    Watanabe, M
    Aoki, Y
    Tomita, M
    Sato, T
    Takaki, Y
    Kato, N
    Kikuchi, M
    Kase, H
    Tanaka, K
    GYNECOLOGIC ONCOLOGY, 2002, 84 (02) : 335 - 338
  • [48] Acute pancreatitis induced by paclitaxel and carboplatin therapy in an ovarian cancer patient
    Shintani, D.
    Yoshida, H.
    Imai, Y.
    Fujiwara, K.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2016, 37 (02) : 286 - 287
  • [49] A clinical and pharmacokinetic study of the combination of carboplatin and paclitaxel for epithelial ovarian cancer
    Siddiqui, N
    Boddy, AV
    Thomas, HD
    Bailey, NP
    Robson, L
    Lind, MJ
    Calvert, AH
    BRITISH JOURNAL OF CANCER, 1997, 75 (02) : 287 - 294
  • [50] Paclitaxel/carboplatin versus topotecan/paclitaxel/carboplatin in patients with FIGO suboptimally resected stage III-IV epithelial ovarian cancer a multicenter, randomized study
    Bolis, Giorgio
    Scarfone, Giovanna
    Raspagliesi, Francesco
    Mangili, Giorgia
    Danese, Saverio
    Scollo, Paolo
    Lo Russo, Domenica
    Villa, Antonella
    Aimone, Paola Daniela
    Scambia, Giovanni
    EUROPEAN JOURNAL OF CANCER, 2010, 46 (16) : 2905 - 2912
12345